Paradox of Bcl-2 (and p53): why may apoptosis-regulating proteins be irrelevant to cell death?

被引:40
作者
Blagosklonny, MV [1 ]
机构
[1] NIH, Med Branch, Bethesda, MD 20892 USA
关键词
D O I
10.1002/bies.1135
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although the Bcl-2 family members and p53 are involved in the regulation of apoptosis, the status of apoptotic machinery (eg caspases) plays a major role in determining the mode and timing of cell death. If the apoptotic machinery is lost, inhibited, or intrinsically inactivated, the "death stars", Bcl-2 and p53, may become irrelevant to cell death. In this light, high levels of Bcl-2 may indicate that downstream apoptotic pathways are still functional. This explains why Bcl-2 overexpression can be a marker of chemosensitivity and favorable prognosis in certain cancers and why retention of wild-type p53 may manifest inactivation of caspases in aggressive cancers. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:947 / 953
页数:7
相关论文
共 92 条
  • [1] Life-or-death decisions by the Bcl-2 protein family
    Adams, JM
    Cory, S
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2001, 26 (01) : 61 - 66
  • [2] Protease inhibitor-induced apoptosis:: accumulation of wt p53, p21WAF1/CIP1 and induction of apoptosis are independent markers of proteasome inhibition
    An, WG
    Hwang, SG
    Trepel, JB
    Blagosklonny, MV
    [J]. LEUKEMIA, 2000, 14 (07) : 1276 - 1283
  • [3] Blagosklonny MV, 1996, INT J CANCER, V67, P386, DOI 10.1002/(SICI)1097-0215(19960729)67:3<386::AID-IJC13>3.0.CO
  • [4] 2-6
  • [5] Unwinding the loop of Bcl-2 phosphorylation
    Blagosklonny, MV
    [J]. LEUKEMIA, 2001, 15 (06) : 869 - 874
  • [6] The Hsp90 inhibitor geldanamycin selectively sensitizes Bcr-Abl-expressing leukemia cells to cytotoxic chemotherapy
    Blagosklonny, MV
    Fojo, T
    Bhalla, KN
    Kim, JS
    Trepel, JB
    Figg, WD
    Rivera, Y
    Neckers, LM
    [J]. LEUKEMIA, 2001, 15 (10) : 1537 - 1543
  • [7] Cell death beyond apoptosis
    Blagosklonny, MV
    [J]. LEUKEMIA, 2000, 14 (08) : 1502 - 1508
  • [8] Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine dependency of human and murine hematopoietic cells
    Blalock, WL
    Moye, PW
    Chang, F
    Pearce, M
    Steelman, LS
    McMahon, M
    McCubrey, JA
    [J]. LEUKEMIA, 2000, 14 (06) : 1080 - 1096
  • [9] Blanc C, 2000, CANCER RES, V60, P4386
  • [10] Apoptosis without caspases: an inefficient molecular guillotine?
    Borner, C
    Monney, L
    [J]. CELL DEATH AND DIFFERENTIATION, 1999, 6 (06) : 497 - 507